In vivo and in vitro pharmacological activities of Tacca integrifolia rhizome and investigation of possible lead compounds against breast cancer through in silico approaches

Clinical Phytoscience

International Journal of Phytomedicine and Phytotherapy

Table 6 Pass prediction of betulinic acid, catsanogenin, quercetin-3-α-arabinoside, chantrieroside A, taccasuboside D, n-triacontanol, taccabulin A, taccalonolide AA, taccalonolide AB, taccalonolide Z for antineoplastic (breast cancer) and antinociceptive activity

Compounds	Pass prediction of antineoplastic (breast cancer) activity		Pass prediction of antinociceptive activity
Compounds	Pa	Pi	Pa	Pi
Betulinic acid	0.723	0.005	0.768	0.002
Catsanogenin	0.510	0.018	0.790	0.002
Quercetin-3-α-arabinoside	0.628	0.009	0.352	0.144
Chantrieroside A	0.559	0.014	0.445	0.075
Taccasuboside D	0.389	0.033	0.591	0.009
n-triacontanol	–	–	0.509	0.031
Taccabulin A	0.349	0.042	0.413	0.099
Taccalonolide AA	0.408	0.030	–	–
Taccalonolide AB	0.475	0.022	–	–
Taccalonolide Z	0.475	0.024	–	–